NCT03196180 2025-04-08
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
Clinical Trials
11 trialsNCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT05405270 2023-09-11
PRedICT-TOPIC
Catharina Ziekenhuis Eindhoven
Recruiting
NCT00788164 2023-08-31
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT04859361 2021-05-03
Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ
University Medical Centre Maribor
Phase NA Unknown
NCT02917746 2018-08-16
TOPIC-3
Maastricht University Medical Center
Phase NA Unknown
NCT00988559 2018-07-09
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT02669459 2018-02-06
TopIC-2
Erasmus Medical Center
Phase 3 Unknown
NCT03206138 2017-07-02
Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.
Seoul St. Mary's Hospital
Phase NA Unknown
NCT02130323 2017-06-27
Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
United States Naval Medical Center, San Diego
Phase 2/3 Completed
NCT00941252 2011-01-24
ITIC
Medical University of Vienna
Phase 2/3 Completed